Skip to main content
PAS 2024 Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Pre-Conference Ticketed Event
Pre-Conference Ticketed Event
APA Award Winner
APA Award Winner
APS Award Winner
APS Award Winner
ASPN Award Winner
ASPN Award Winner
SPR Award Winner
SPR Award Winner
On Demand Presentation
On Demand Presentation
Poster Icons
SPR Award Winner
SPR Award Winner
Back
Evaluation ViewAttendees 19
Hot Topic Symposia

COVID-19

Epidemiology

Immunizations/Delivery

Infectious Diseases

Trainee
Session Type: Hot Topic Symposia

COVID-19 in children -How did we respond to our children?

Monday, May 6, 2024
8:00 AM – 9:30 AM ET
Location: Metro Toronto Convention Centre: 107
CE: Live CME: 1.5

Selected By: ASPR
Co-sponsored By: PIDS
Disclosure(s):
Kensuke Shoji, MD, PhD: AstraZeneca K.K. (Terminated, October 8, 2022) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness); Dai-ichi Life Holdings, Inc (Terminated, March 21, 2023) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness); Gilead Sciences, Inc. (Terminated, December 18, 2022) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness); KYORIN Pharmaceutical Co.,Ltd. (Terminated, February 22, 2023) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness); Meiji Seika Pharma Co., Ltd. (Terminated, July 23, 2022) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness, Speaker Honorarium including speakers bureau, symposia, and expert witness); Moderna Japan Co., Ltd. (Terminated, July 27, 2023) (Products/Services: Advisory Committee); Novartis Pharma Co., Ltd. (Terminated, November 29, 2022) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness); Viatrs, Inc. (Terminated, June 3, 2022) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness)
Michelle Gill, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Session

Description: Coronavirus disease 2019 (COVID-19) was first reported in December 2019 and rapidly spread worldwide. At the beginning of the epidemic, COVID-19 cases were mainly among adults and the elderly, but the distribution of COVID-19 vaccine to adults and the emergence of highly infectious variant of concerns led to increase in pediatric cases. As information on COVID-19 gradually increased, the epidemiological characteristics of COVID-19, such as the number of patients and mortality rates, differed among countries and regions. In addition, responses to COVID-19 in children including infection control measures, school closure, and COVID-19 vaccination policy varied from country to country,.
This symposium was designed to compare the epidemiological and clinical characteristics of COVID-19 in children and the responses in each country, and to contribute to future responses to COVID-19 and new emerging infectious disease control measures. Each speaker will describe the epidemiology and clinical characteristics, the current status of the COVID-19 vaccine, and the response to pediatric COVID-19 in each country.

Learning Objectives:

  • Understand an overview of the clinical and epidemiological characteristics of pediatric COVID-19 across various countries.
  • Understand the value of engaging community pediatricians and local leaders to collaboratively advocate for vulnerable children during a global pandemic.
  • Apply this knowledge to future strategies in addressing new emerging infectious diseases.

Presentations:

  • 8:00 AM – 8:02 AM ET
    Opening Remarks

    Speaker: Kensuke Shoji, MD, PhD (he/him/his) – Japan Pediatric Society, Asian Society for Pediatric Research

  • 8:02 AM – 8:22 AM ET
    Lessons from the COVID-19 pandemic: The Value of Clinical and Community Collaborations

    Speaker: Michelle Gill, MD, PhD (she/her/hers) – Washington University in St. Louis School of Medicine

  • 8:22 AM – 8:42 AM ET
    Reflections from across The Atlantic (the UK)

    Speaker: Shunmay Yeung, PhD, MBBS, FRCPCH, MRCP, DTM&H (she/her/hers) – London School of Hygiene and Tropical Medicine

  • 8:42 AM – 9:02 AM ET
    Clinical and epidemiological characteristics of COVID-19 in children in Japan

    Speaker: Kensuke Shoji, MD, PhD (he/him/his) – Japan Pediatric Society, Asian Society for Pediatric Research

  • 9:02 AM – 9:22 AM ET
    Omicron BA.2 disease and mRNA /inactivated Covid-19 vaccination in Hong Kong Children

    Speaker: Yu-Lung Lau, MD (he/him/his) – The University of Hong Kong

  • 9:22 AM – 9:30 AM ET
    Closing Remarks

    Speaker: Michelle Gill, MD, PhD (she/her/hers) – Washington University in St. Louis School of Medicine